Download the Free Prime PubMed App to your smartphone or tablet.

Available for iPhone or iPad:

Unbound PubMed app for iOS iPhone iPadAlso Available:
Unbound PubMed app for Android

Available for Mac and Windows Desktops and laptops:

Unbound PubMed app for WindowsUnbound PubMed app for MAC OS Yosemite Macbook Air pro
(chiasm chiasma)
5,453 results
  • [Interdisciplinary Management of Sellar Masses]. [Journal Article]
  • PPraxis (Bern 1994) 2019; 108(9):599-608
  • Bischofberger-Baumann B, Ebert A, … Bilz S
  • Interdisciplinary Management of Sellar Masses Abstract. Sellar masses may present with an impairment of pituitary function (hypopituitarism), hormone hypersecretion (prolactinoma, acromegaly, glucoco…
  • Visually evoked potentials. [Journal Article]
  • HCHandb Clin Neurol 2019; 160:501-522
  • Creel DJ
  • The term visually evoked potential (VEP) refers to electrical potentials recorded from scalp overlying visual cortex that have been extracted from the electroencephalogram by signal averaging. Usuall…
  • Wiring the Binocular Visual Pathways. [Review]
  • IJInt J Mol Sci 2019 Jul 04; 20(13)
  • Murcia-Belmonte V, Erskine L
  • Retinal ganglion cells (RGCs) extend axons out of the retina to transmit visual information to the brain. These connections are established during development through the navigation of RGC axons alon…
  • The Human Visual Pathway Communicates Directly With the Subarachnoid Space. [Journal Article]
  • IOInvest Ophthalmol Vis Sci 2019 Jun 03; 60(7):2773-2780
  • Jacobsen HH, Ringstad G, … Eide PK
  • CONCLUSIONS: The results indicate direct communication between CSF of subarachnoid space and the extravascular space of the human visual pathway. Extravascular entry of the CSF tracer is a prerequisite for a glymphatic system, the present findings may suggest its presence. The existence of a glymphatic system in the human visual pathway could bring novel perspectives on the pathophysiology and treatment of ophthalmic diseases.
  • Current treatment of optic nerve gliomas. [Journal Article]
  • COCurr Opin Ophthalmol 2019 Jun 24
  • Farazdaghi MK, Katowitz WR, Avery RA
  • CONCLUSIONS: Although standard chemotherapy remains the mainstay of ONG treatment, newer molecularly targeted therapies such as mitogen-activated protein kinase kinase inhibitors and bevacizumab represent a promising new treatment modality, and clinical studies are ongoing.
New Search Next